MP32 - A Health Care Quality Landscape Analysis of Schizophrenia to Identify Key Opportunities for Improvement

Monday, May 5, 2025

12:30 PM – 1:00 PM ET

Location: Hall BCD

This session will explore the current landscape of schizophrenia care in the U.S., focusing on cognitive impairments and negative symptoms. Attendees will learn about existing gaps in quality measures and initiatives and discover opportunities for advancing care through targeted quality improvement tactics and stakeholder collaboration. Join us to understand how integrating emerging assessment tools can enhance patient outcomes in community mental health settings.

Learning Objectives:

Explore the current status of schizophrenia care within the U.S. healthcare quality landscape, with a focus on cognitive impairment associated with schizophrenia and negative symptoms.
Identify the existing gaps in quality measures and tactics specific to schizophrenia, especially in the areas of cognitive impairment associated with schizophrenia and negative symptoms.
Highlight the opportunities for collaboration with clinical, advocacy, and quality stakeholders to enhance the quality of schizophrenia healthcare delivery.

Poster Presenter(s)

NW

Nancy Witkowski, RN BSN CPHQ

Director, Healthcare Quality
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut
Joe Parks, MD

Principal Medical Advisor
National Council for Mental Wellbeing
Washington, District of Columbia